{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-100574","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2026-09-16T21:08:11+00:00","discovered_at":"2026-09-16T21:10:00.352682+00:00","generated_at":"2026-09-16T21:10:06.236850+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Adial amends warrant deals to reclassify $22.7M liability to equity, regain Nasdaq compliance","bullets":["On Sep 16, 2026, amended Purchase and Note Exchange Agreements to remove Penalty Provision, add lock-up on warrant shares.","Milestone Warrant rights reclassified from liability to equity: $19.7M (PIPE) and $3.0M (noteholders) to additional paid-in capital.","Pro forma equity improves from $(38.4M) deficit to $22.9M positive as of Jun 30, 2026.","Series A Preferred (12,930.617 shares) converts to 12.93M common shares; total common shares pro forma 15.56M.","Amendments intended to satisfy Nasdaq continued listing and initial listing standards for change of control at Sep 17 Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-100574","json":"https://secwatch.observer/filing/0001213900-26-100574.json","markdown":"https://secwatch.observer/filing/0001213900-26-100574.md","text":"https://secwatch.observer/filing/0001213900-26-100574.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026100574/0001213900-26-100574-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390026100574/ea0305675-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T21:10:06.236850+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}